http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103450086-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_354e132d58215c4d082342a48587f30f
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4174
filingDate 2013-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26d653dac9f4f2fa456daf048371a47c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b53c98d5e00344db9b438bb811f5b3b1
publicationDate 2015-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103450086-B
titleOfInvention Ozagrel compound, preparation method and pharmaceutical composition of ozagrel compound
abstract The invention belongs to the technical field of medicines, and particularly relates to an ozagrel compound, a preparation method and a pharmaceutical composition of the ozagrel compound. The X-ray powder diffraction spectrogram obtained by Cu-K alpha-ray measurement is shown in a figure 1; and the structural formula is as shown in a formula (I). The ozagrel compound is a novel crystal form which is different from that in the prior art. The novel crystal form ozagrel compound has humidity, temperature and illumination stability obviously superior to those of the ozagrel in the prior art; sodium ozagrel for injection, prepared from the ozagrel compound of such crystal form, is high in redissolving performance, and insoluble particles have smaller change after an injection solution is combined; after redissolving, the contents of specific impurities I and II in the solution are obviously less than those in the prior art.
priorityDate 2013-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP36423
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419566278
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9DBX6
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411060862
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20849128
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544577
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282411
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559283
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP47787
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534740
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID641256
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6228
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A3Q1LIA5
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490115
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ2PG45
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ96SQ9
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ2KIG5
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445049
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6212
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282440
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836

Total number of triples: 46.